Citi analyst Patrick Donnelly resumed coverage of Waters (WAT) with a Buy rating and $425 price target The firm sees upside to the company’s’ earnings estimates from likely conservative synergy assumptions. Citi also likes Waters’ base business, saying the biopharma market is getting better.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: